Compare Archer-Daniels-Midland Co (ADM) vs Illumina, Inc. (ILMN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Archer-Daniels-Midland Co vs Illumina, Inc. — how do they compare? Archer-Daniels-Midland Co trades at $80.75 (market cap $38.79B), while Illumina, Inc. trades at $193.06 (market cap $28.96B). The key difference: Archer-Daniels-Midland Co is the larger of the two by market cap, and Archer-Daniels-Midland Co pays a 2.58% dividend while Illumina, Inc. pays none. Which is the better fit depends on your goals.
| ADM | ILMN | |
|---|---|---|
Market Cap | $38.79B | $28.96B |
Sector | Consumer Staples | Health |
52-Week High | $87.32 | $205.10 |
52-Week Low | $56.00 | $91.00 |
Enterprise Value | $47.04B | $30.32B |
Dividend Yield | 2.58% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Archer-Daniels-Midland Co
Archer-Daniels Midland is a major processor of oilseeds, corn, wheat, and other agricultural commodities. Additionally, the company owns an extensive network of logistical assets to store and transport crops around the globe. ADM also runs a nutrition business that focuses on both human and animal ingredients. The company is also a large producer of corn-based sweeteners, starches, and ethanol.
Read more on ADM →About Illumina, Inc.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →
